289 related articles for article (PubMed ID: 19093956)
1. Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts.
Broliden K; Haase AT; Ahuja SK; Shearer GM; Andersson J
J Intern Med; 2009 Jan; 265(1):5-17. PubMed ID: 19093956
[No Abstract] [Full Text] [Related]
2. Mucosal-targeted AIDS vaccines: the next generation?
Lekkerkerker AN; Van Kooyk Y; Geijtenbeek TB
Trends Microbiol; 2004 Oct; 12(10):447-50. PubMed ID: 15381193
[No Abstract] [Full Text] [Related]
3. Mucosal immunity, HIV transmission, and AIDS.
Miller CJ; McGhee JR; Gardner MB
Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
[No Abstract] [Full Text] [Related]
4. Progress towards an AIDS mucosal vaccine: an overview.
Yuki Y; Nochi T; Kiyono H
Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S35-44. PubMed ID: 17652028
[TBL] [Abstract][Full Text] [Related]
5. AIDS vaccine development.
Lévy JP
Science; 1998 May; 280(5365):806-7. PubMed ID: 9599149
[No Abstract] [Full Text] [Related]
6. Targeting early infection to prevent HIV-1 mucosal transmission.
Haase AT
Nature; 2010 Mar; 464(7286):217-23. PubMed ID: 20220840
[TBL] [Abstract][Full Text] [Related]
7. HIV-1/AIDS vaccine development: are we in the darkness.
Qiu C; Xu JQ
Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
[No Abstract] [Full Text] [Related]
8. India targets local HIV strain in test of AIDS vaccine.
Jayaraman KS
Nature; 2004 Jan; 427(6971):185. PubMed ID: 14724601
[No Abstract] [Full Text] [Related]
9. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
Belyakov IM; Ahlers JD
Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298
[TBL] [Abstract][Full Text] [Related]
10. Is an effective HIV vaccine feasible?
Cohen J
Science; 2005 Jul; 309(5731):99. PubMed ID: 15994545
[No Abstract] [Full Text] [Related]
11. Mucosally-targeted HIV-1 vaccines.
Wegmann F
Hum Vaccin; 2011 Sep; 7(9):982-5. PubMed ID: 21892008
[No Abstract] [Full Text] [Related]
12. HIV/AIDS vaccines: a need for new concepts?
Girard MP; Bansal GP
Int Rev Immunol; 2008; 27(6):447-71. PubMed ID: 19065351
[TBL] [Abstract][Full Text] [Related]
13. Developments in preclinical AIDS vaccine efficacy models.
Bogers WM; Cheng-Mayer C; Montelaro RC
AIDS; 2000; 14 Suppl 3():S141-51. PubMed ID: 11086857
[No Abstract] [Full Text] [Related]
14. [AIDS vaccine].
Sikorska EJ
Pneumonol Alergol Pol; 1991; 59(3-4):146-52. PubMed ID: 1843911
[No Abstract] [Full Text] [Related]
15. The prospective preventative HIV vaccine based on modified poliovirus.
Zhang YD; Lu XL; Li NF
Med Hypotheses; 2007; 68(6):1258-61. PubMed ID: 17196342
[TBL] [Abstract][Full Text] [Related]
16. Is AIDS vaccine research at a turning point?
Levy JP
J Hum Virol; 2000; 3(2):83-7. PubMed ID: 10850894
[TBL] [Abstract][Full Text] [Related]
17. [The virus can not yet be eradicated. "HIV-infected patients cannot be completely cured"].
Hellbom K
Krankenpfl J; 1998; 36(7-8):274. PubMed ID: 9775853
[No Abstract] [Full Text] [Related]
18. 25 years of HIV research! ... and what about a vaccine?
Appay V
Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
[TBL] [Abstract][Full Text] [Related]
19. How should the potency of HIV vaccine candidates be determined?
Sheets R; Bean P
Am Clin Lab; 2000; 19(8):23. PubMed ID: 11146989
[No Abstract] [Full Text] [Related]
20. Mathematical study of a staged-progression HIV model with imperfect vaccine.
Gumel AB; McCluskey CC; van den Driessche P
Bull Math Biol; 2006 Nov; 68(8):2105-28. PubMed ID: 16868850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
